Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Increase in the tight junction protein claudin-1 in intestinal inflammation.
Poritz LS, Harris LR 3rd, Kelly AA, Koltun WA.
Dig Dis Sci. 2011 Oct;56(10):2802-9. Epub 2011 Jul 12.
Related citations
Magnetic resonance enterography: safe and effective imaging for stricturing Crohn's disease.
Ha CY, Kumar N, Raptis CA, Narra VR, Ciorba MA.
Dig Dis Sci. 2011 Oct;56(10):2906-13. Epub 2011 Jun 19.
NaOH-induced Crohn's colitis in rats: a novel experimental model.
Koçak E, Köklü S, Akbal E, Taş A, Karaca G, Astarcı MH, Güven B, Can M.
Dig Dis Sci. 2011 Oct;56(10):2833-7. Epub 2011 Apr 19.
Fast routes to new therapies: what do epilepsy and inflammatory bowel disease have in common?
Nimgaonkar A, Shah SB.
Gastroenterology. 2012 Mar;142(3):670-1. Epub 2012 Jan 24. No abstract available.
HLA-Cw*1202-B*5201-DRB1*1502 haplotype increases risk for ulcerative colitis but reduces risk for Crohn's disease.
Asakura H.
Gastroenterology. 2012 Mar;142(3):e27-8; author reply e28-9. Epub 2012 Jan 24. No abstract available.
Mesenteric fat in Crohn's disease: the hot spot of inflammation?
Siegmund B.
Gut. 2012 Jan;61(1):3-5. Epub 2011 Nov 7. No abstract available.
Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease.
Peyrin-Biroulet L, Gonzalez F, Dubuquoy L, Rousseaux C, Dubuquoy C, Decourcelle C, Saudemont A, Tachon M, Béclin E, Odou MF, Neut C, Colombel JF, Desreumaux P.
Gut. 2012 Jan;61(1):78-85. Epub 2011 Sep 21.
Visceral adipocytes: old actors in obesity and new protagonists in Crohn's disease?
Zulian A, Cancello R, Micheletto G, Gentilini D, Gilardini L, Danelli P, Invitti C.
Gut. 2012 Jan;61(1):86-94. Epub 2011 Sep 19.
Antibodies to GP2, the major zymogen granule membrane glycoprotein, in inflammatory bowel diseases.
Op De Beéck K, Vermeire S, Rutgeerts P, Bossuyt X.
Gut. 2012 Jan;61(1):162-4; author reply 164-5. Epub 2010 Dec 29. No abstract available.
Performance of interferon-gamma release assays in patients with inflammatory bowel disease: A systematic review and meta-analysis.
Shahidi N, Fu YT, Qian H, Bressler B.
Inflamm Bowel Dis. 2012 Jan 31. doi: 10.1002/ibd.22901. [Epub ahead of print]
Adrenomedullin: A novel therapy for intractable ulcerative colitis.
Ashizuka S, Kita T, Inatsu H, Kitamura K.
Inflamm Bowel Dis. 2012 Jan 31. doi: 10.1002/ibd.22891. [Epub ahead of print] No abstract available.
Risk factors of anxiety and depression in inflammatory bowel disease.
Nahon S, Lahmek P, Durance C, Olympie A, Lesgourgues B, Colombel JF, Gendre JP.
Inflamm Bowel Dis. 2012 Jan 31. doi: 10.1002/ibd.22888. [Epub ahead of print]
Serum anti-glycan antibody biomarkers for inflammatory bowel disease diagnosis and progression: A systematic review and meta-analysis.
Kaul A, Hutfless S, Liu L, Bayless TM, Marohn MR, Li X.
Inflamm Bowel Dis. 2012 Jan 31. doi: 10.1002/ibd.22862. [Epub ahead of print]
Pretravel preparation and travel-related morbidity in patients with inflammatory bowel disease.
Soonawala D, van Eggermond AM, Fidder H, Visser LG.
Inflamm Bowel Dis. 2012 Jan 31. doi: 10.1002/ibd.22903. [Epub ahead of print]
Involvement of mycobacterium avium subspecies paratuberculosis in TNF-α production from macrophage: possible link between MAP and immune response in Crohn's disease.
Nakase H, Tamaki H, Matsuura M, Chiba T, Okazaki K.
Inflamm Bowel Dis. 2011 Nov;17(11):E140-2. doi: 10.1002/ibd.21750. No abstract available.
Should patients be screened for hereditary cancer syndromes before starting anti-TNF-α therapy?
Subramaniam K, Tucker K, Craft P, Pavli P.
Inflamm Bowel Dis. 2011 Nov;17(11):E151-2. doi: 10.1002/ibd.21883. Epub 2011 Aug 30. No abstract available.
Associations between variants in the ABCB1 (MDR1) gene and corticosteroid dependence in children with Crohn's disease.
Krupoves A, Mack D, Seidman E, Deslandres C, Amre D.
Inflamm Bowel Dis. 2011 Nov;17(11):2308-17. doi: 10.1002/ibd.21608. Epub 2011 Jan 6.
Severe agranulocytosis following first infliximab infusion in Crohn's disease.
Rosales-Zábal JM, Fernández-Pérez F, Albandea-Moreno C, Vera-Rivero FM, Navarro-Jarabo JM.
Inflamm Bowel Dis. 2011 Nov;17(11):E147-8. doi: 10.1002/ibd.21829. Epub 2011 Aug 9. No abstract available.
Severe CMV-related pneumonia complicated by the hemophagocytic lymphohistiocytic (HLH) syndrome in quiescent Crohn's colitis: harmful cure?
Presti MA, Costantino G, Della Torre A, Belvedere A, Cascio A, Fries W.
Inflamm Bowel Dis. 2011 Nov;17(11):E145-6. doi: 10.1002/ibd.21828. Epub 2011 Aug 8. No abstract available.
Hemophagocytic lymphohistiocytosis in Crohn's disease associated with primary infection by Epstein-Barr virus.
Salado CT, Gallego AG, Carnerero EL, De la Cruz Ramírez D, Justiniano JM, Galán JL, Guisado MA.
Inflamm Bowel Dis. 2011 Nov;17(11):E143-4. doi: 10.1002/ibd.21827. Epub 2011 Jul 26. No abstract available.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on